Wellcome Sanger Institute
The Wellcome Sanger Institute is one of the premier centres of genomic discovery and understanding in the world. It leads ambitious collaborations across the globe to provide the foundations for further research and transformative healthcare innovations.
| Telephone: | +44 (0)1223 834 244 |
|---|---|
| Address: | Wellcome Genome Campus, Hinxton |
| Postcode: | CB10 1SA |
| Country: | United Kingdom |
| Website: | http://www.sanger.ac.uk |
| Membership type: | Corporate 51+ (£1,000+VAT pa) |
Its success is founded on the expertise and knowledge of its people and the Institute seeks to share its discoveries and techniques with the next generation of genomics scientists and researchers worldwide.
Mice reveal 38 new genes involved in hearing loss
Multiple new genes involved in hearing loss have been revealed in a huge study of mouse mutants by researchers from the Wellcome Sanger Institute and King’s College London, and colleagues. The new genes reveal the metabolic pathways and regulatory processes involved in hearing.
15 April 2019Read in full
New cancer drug targets accelerate path to precision medicine
Researchers discover thousands of genes essential for cancer’s survival and rank which ones show the most promise as drug targets for developing new treatments.
11 April 2019Read in full
Genetic code of WWI soldier’s cholera mapped
The oldest publicly-available strain of the cholera-causing bacterial species, Vibrio cholerae, has had its genetic code read for the first time by researchers at the Wellcome Sanger Institute and their collaborators. The bacterium was isolated from a British soldier during World War One (WWI) and stored for over 100 years before being revived and sequenced.
10 April 2019Read in full
Major mutation pattern in cancer occurs in bursts
Researchers have created a huge resource for investigating the biological mechanisms that cause cancer. The scientists from the Wellcome Sanger Institute and their collaborators identified which patterns of DNA damage - mutational fingerprints that represent the origins of cancer - were present in over a thousand human cancer cell lines.
11 March 2019Read in full
Improving global surveillance of antibiotic resistance
A World Health Organization (WHO) Technical Note has been published that will enable health authorities to make informed choices on the most appropriate molecular tests in order to achieve a clearer picture of antimicrobial resistance globally.
28 February 2019Read in full
Cancer comparison across species highlights new drug targets
Cancer genes in mucosal melanoma, a rare and poorly understood subtype of melanoma, have been compared in humans, dogs and horses for the first time by scientists at the Wellcome Sanger Institute and their collaborators. Researchers sequenced the genomes of the same cancer across different species to pin-point key cancer genes.
13 February 2019Read in full
100 cancer organoid models developed by Sanger Institute scientists
Researchers at the Wellcome Sanger Institute have developed 100 cancer organoids.The work was co-funded by Cancer Research UK and the Sanger Institute and leads the UK effort as part of the international Human Cancer Model Initiative (HCMI). The organoids will soon be available for researchers, together with associated data including whole genome sequences.
6 February 2019Read in full
More than 100 new gut bacteria discovered in human microbiome
Scientists working on the gut microbiome* have discovered and isolated more than 100 completely new species of bacteria from healthy people’s intestines.
5 February 2019Read in full
Immune master regulator orchestrates responses to parasite infection
A new study has identified the master regulator that maintains a healthy gut and limits damage by parasitic whipworms. Researchers from the Wellcome Sanger Institute and collaborators have revealed that the interleukin 10 receptor (IL-10R) is critical to prevent uncontrolled whipworm infection in mice and a damaging immune response in the gut.
1 February 2019Read in full
Genetic testing gives answers on developmental disorders during pregnancy
Genetic testing improves the diagnoses of abnormalities in developing babies that are picked up during ultrasound scans, scientists report in The Lancet.
1 February 2019Read in full
|
16/04/2019
Conference & Events Office AdministratorThe Advanced Courses and Conference team is looking for an experienced Administrator
Location: Cambridge
Salary: Up to £20,000 |
More Info |
|
|
16/04/2019
Postdoctoral Fellow - Functional GenomicsWe have an exciting opportunity for a Postdoctoral Fellow
Location: Cambridge
Salary: £20,000 - £30,000 |
More Info |
|
|
16/04/2019
Senior Staff Scientist - Functional GenomicsWe are recruiting for a Senior Staff Scientist in Carl Anderson's group
Location: Cambridge
Salary: £40,000 - £50,000 |
More Info |
|
|
15/04/2019
Compliance Officer (Nagoya Protocol) - 2 year FTCWe're hiring!
Location: Cambridge
Salary: £20,000 - £30,000 |
More Info |
|
|
15/04/2019
HR AdministratorOur HR team are hiring!
Location: Cambridge
Salary: Up to £20,000 |
More Info |
|
|
15/04/2019
Legal Counsel (part time and flexi working considered)We're hiring!
Location: Cambridge
Salary: £50,000 - £60,000 |
More Info |
|
|
15/04/2019
Senior HR Systems AnalystWe're hiring!
Location: Cambridge
Salary: £20,000 - £30,000 |
More Info |
|
|
15/04/2019
Senior Legal CounselWe're hiring!
Location: Cambridge
Salary: £50,000 - £60,000 |
More Info |
|
|
10/04/2019
Senior Research Assistant - Cellular Generation and PhenotypingA rare opportunity has arisen for a histologist to support the Cellular Generation and Phenotyping team (CGaP) here at the Sange...
Location: Cambridge
Salary: £20,000 - £30,000 |
More Info |
|
|
09/04/2019
Computational Biologist/BioinformaticianWellcome Sanger Institute is recruiting for a Computational Biologist/Bioinformatician to join Dr. Maya Ghoussaini's team
Location: Cambridge
Salary: £20,000 - £30,000 |
More Info |
Follow us on